Articles dans des revues avec comité de lecture (12)
  1. 1. Biset, N., Lelubre, M., Pochet, S., & De Vriese, C. (2023). Asthma and COPD: Comparison with International Guidelines and Medication Adherence in Belgium. Pharmaceuticals, 16(7). doi:10.3390/ph16071030
  2. 2. Wuyts, J., Maesschalck, J., De Wulf, I., Lelubre, M., Foubert, K., De Vriese, C., Boussery, K., Goderis, G., De Lepeleire, J., & Foulon, V. (2020). Studying the impact of a medication use evaluation by the community pharmacist (Simenon): Drug-related problems and associated variables. Research in social & administrative pharmacy : RSAP, 16(8), 1100-1110. doi:10.1016/j.sapharm.2019.11.008
  3. 3. Foubert, K., Mehuys, E., Maesschalck, J., De Wulf, I., Wuyts, J., Foulon, V., Lelubre, M., De Vriese, C., Somers, A., Petrovic, M., & Boussery, K. (2019). Pharmacist-led medication review in community-dwelling older patients using the GheOP3 S-tool: General practitioners' acceptance and implementation of pharmacists' recommendations. Journal of evaluation in clinical practice. doi:10.1111/jep.13241
  4. 4. Koubaity, M., Lelubre, M., Sansterre, G., Amighi, K., & De Vriese, C. (2019). Adaptation and validation of PCNE drug-related problem classification v6.2 in French-speaking Belgian community pharmacies. International Journal of Clinical Pharmacy, 41(1), 244-250. doi:10.1007/s11096-018-0773-y
  5. 5. Foubert, K., Mehuys, E., Maesschalck, J., De Wulf, I., Wuyts, J., Foulon, V., Lelubre, M., De Vriese, C., Somers, A., Petrovic, M., & Boussery, K. (2019). Pharmacist-led medication review in community-dwelling older patients using the GheOP3S-tool: General practitioners' acceptance and implementation of pharmacists' recommendations. Journal of evaluation in clinical practice. doi:10.1111/jep.13241
  6. 6. Lelubre, M., Clerc, O., Grosjean, M., Amighi, K., De Vriese, C., Bugnon, O., & Schneider, M. P. (2018). Implementation study of an interprofessional medication adherence program for HIV patients in Switzerland: quantitative and qualitative implementation results. BMC health services research, 18, 874. doi:10.1186/s12913-018-3641-5
  7. 7. Lelubre, M., Wuyts, J., Maesschalck, J., Duquet [EXT], N., Foubert, K., Hutsebaut, C., Moullin, J., De Wulf [EXT], I., Boussery, K., Foulon, V., & De Vriese, C. (2018). Implementation study of an intermediate medication review in Belgian community pharmacies. Research in Social and Administrative Pharmacy.
  8. 8. Lelubre, M., Clerc, O., Grosjean, M., Amighi, K., De Vriese, C., Bugnon, O., & Schneider, M. P. (2018). Implementation of an interprofessional medication adherence program for HIV patients: description of the process using the framework for the implementation of services in pharmacy. BMC health services research, 18, 698. doi:10.1186/s12913-018-3509-8
  9. 9. Lelubre, M., Hamdani, J., Senterre, C., Amighi, K., Peres, M., Schneider, M. P., Bugnon, O., & De Vriese, C. (2018). Evaluation of compliance with isotretinoin PPP recommendations and exploration of reasons for non-compliance: Survey among French-speaking health care professionals and patients in Belgium. Pharmacoepidemiology and drug safety, 27(6), 668-673. doi:10.1002/pds.4441
  10. 10. Biset, N., Lelubre, M., Senterre, C., Amighi, K., Bugnon, O., Schneider, M. P., & De Vriese, C. (2018). Assessment of medication adherence and responsible use of isotretinoin and contraception through belgian community pharmacies by using pharmacy refill data. Patient Preference and Adherence, 12, 153-161. doi:10.2147/PPA.S149355
  11. 11. Lelubre, M., Koubaity, M., De Wulf [EXT], I., Boussery, K., De Meyer, G. R., Foulon, V., Lacour, V., Steurbaut, S., Van Hees, T., Amighi, K., Bugnon, O., & De Vriese, C. (2016). Fréquence et nature des problems liés aux corticosteroïdes dans les officines publiques de Belgique. Journal de pharmacie de Belgique,(3), 32-41.
  12. 12. Lelubre, M., Kamal, S., Genre, N., Celio, J., Gorgerat, S., Hugentobler Hampai, D., Bourdin, A., Berger, J., Bugnon, O., & Schneider, M. P. (2015). Interdisciplinary Medication Adherence Program: The Example of a University Community Pharmacy in Switzerland. BioMed Research International.
    13. << Précédent 1 2 Suivant >>